Financials · INVX

Innovex International Inc. (INVX) financials

For the twelve months ended Sep 30, 2026, Innovex International Inc. reported $1.02B of revenue and $48.61M of net income.

Revenue, TTM
$1.02B
Revenue growth, YoY
+7.0%
Net income, TTM
$48.61M
Net income growth, YoY
-51.9%
Net margin
4.8%
EPS, diluted, TTM
$0.69
Cash
$188.76M
Total debt
$18.27M
P/E
36.51
P/S
1.74
Market cap
$1.78B
Annual revenue$978.25M
FY2016FY2025
Annual net income$83.30M
FY2016FY2025
Annual free cash flow$43.24M
FY2016FY2023

INVX revenue and earnings growth

INVX revenueQ3 2026$265.05M

Quarter YoY
+10.4%
QoQ
+8.2%
FY YoY
+48.0%
5Y CAGR
+21.8%
10Y CAGR
+1.5%

INVX revenue was $265.05M in fiscal Q3 2026 (ended Sep 30, 2026), up 10.4% from a year earlier and up 8.2% from the prior quarter. For the full fiscal 2025 it was $978.25M, up 48.0% from fiscal 2024. Compound annual growth was +21.8% over 5 years and +1.5% over 10 years. It rose in 5 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.

INVX net incomeQ3 2026$26.29M

Quarter YoY
-33.0%
QoQ
+5.0%
FY YoY
-40.6%
10Y CAGR
-8.0%

INVX net income was $26.29M in fiscal Q3 2026 (ended Sep 30, 2026), down 33.0% from a year earlier and up 5.0% from the prior quarter. For the full fiscal 2025 it was $83.30M, down 40.6% from fiscal 2024. Compound annual growth was -8.0% over 10 years. It rose in 2 of the last 3 fiscal years.

INVX EPSQ3 2026$0.37

Quarter YoY
-35.1%
QoQ
+2.8%
FY YoY
-56.7%

INVX diluted EPS was $0.37 in fiscal Q3 2026 (ended Sep 30, 2026), down 35.1% from a year earlier and up 2.8% from the prior quarter. For the full fiscal 2025 it was $1.20, down 56.7% from fiscal 2024.

Export CSV

Income statement

Income statement
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Revenue$978.25M$660.80M$555.54M$467.19M$322.45M$364.97M$414.81M$384.63M$455.47M$538.73M
Cost of revenue$674.97M$428.17M$360.10M$309.07M$309.27M$269.70M$295.01M$293.57M$330.24M$328.40M
Gross profit$303.28M$232.63M$195.44M$158.12M$13.18M$95.28M$119.80M$91.05M$125.23M$210.33M
Research and development$6.70M$3.70M$3.00M$2.50M------
Selling, general and admin$128.79M$116.18M$72.80M$59.19M$115.04M$95.06M$98.41M$102.10M$113.59M$53.25M
Operating income$132.63M$49.08M$97.28M$75.84M-$125.33M-$63.56M$2.80M-$122.74M-$69.14M$112.86M
Interest expense$2.58M$2.43M$5.51M$4.03M$787.0K$621.0K$314.0K$291.0K$72.0K$28.0K
Pre-tax income$128.53M$142.81M$94.37M$72.93M-$125.55M-$62.05M$10.43M-$114.99M-$65.64M$115.87M
Income tax$45.23M$2.49M$20.44M$9.65M$2.95M-$31.28M$8.71M-$19.29M$34.99M$22.65M
Net income$83.30M$140.32M$73.93M$63.28M-$128.49M-$30.77M$1.72M-$95.69M-$100.64M$93.22M
EPS, basic$1.21$2.82$2.39$2.07-$3.63-$0.87$0.05-$2.58-$2.69$2.48
EPS, diluted$1.20$2.77$2.29$2.01-$3.63-$0.87$0.05-$2.58-$2.69$2.47
Diluted shares69.4M50.6M32.3M31.4M35.3M35.3M36.2M37.1M37.5M37.7M

Balance sheet

Balance sheet
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Cash and equivalents$203.41M$73.28M$7.41M$264.80M$355.45M$345.95M$398.95M$418.10M$493.18M$423.50M
Short-term investments--$25.91M$32.23M$0-----
Receivables$237.77M$239.51M$118.36M$90.86M$100.49M$116.20M$107.63M$118.66M$191.63M$213.51M
Inventory$248.43M$271.17M$141.19M$146.00M$145.72M$212.54M$205.06M$191.19M$291.09M$355.41M
Current assets$728.05M$641.39M$288.27M$750.02M$745.05M$863.19M$880.49M$852.98M$1.01B$1.06B
Goodwill$99.72M$60.18M$23.93M$23.93M--$7.95M$7.71M$47.62M$34.37M
Total assets$1.27B$1.20B$475.30M$969.95M$1.01B$1.15B$1.21B$1.19B$1.40B$1.46B
Current liabilities$148.16M$162.66M$78.62M$87.56M$93.66M$85.51M$96.94M$81.54M$99.91M$101.48M
Long-term debt$18.92M$24.90M$40.57M-------
Total debt$18.92M$24.90M$40.57M-------
Total liabilities$210.61M$239.33M$146.38M$97.60M$113.32M$109.64M$115.86M$96.35M$105.34M$104.98M
Shareholders' equity$1.06B$958.16M$328.92M$251.28M$180.55M$1.04B$1.09B$1.10B$1.29B$1.36B

Cash flow

Cash flow
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Operating cash flow$190.91M$93.44M$75.86M-$5.81M$38.43M-$21.09M$14.68M$45.50M$107.99M$246.52M
Capital expenditures--$32.63M$18.87M$9.99M$11.94M$11.50M$32.06M$27.62M$25.76M
Free cash flow--$43.24M-$24.68M$28.44M-$33.03M$3.18M$13.44M$80.37M$220.76M
Investing cash flow-$18.74M$78.44M-$32.43M-$37.52M-$3.21M-$5.63M-$8.47M-$15.17M-$44.89M-$157.85M
Financing cash flow-$44.92M-$103.07M-$44.56M$42.28M-$24.30M-$25.18M-$24.57M-$99.20M$560.0K-$21.89M
Dividends paid$0$74.98M$0$0------
Share repurchases--$0$20.81M$24.19M$25.00M$26.57M$100.00M$0$24.23M
Stock-based compensation$13.80M$13.25M$1.96M$907.0K$14.89M$12.91M$15.72M$13.46M$14.27M$12.22M
Depreciation and amortization$60.74M$31.21M$22.66M$18.47M$30.38M$32.39M$34.02M$35.31M$40.97M$31.86M

Key ratios

Key ratios
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Revenue growth, YoY48.0%18.9%18.9%44.9%-11.7%-12.0%7.8%-15.6%-15.5%-36.2%
Net income growth, YoY-40.6%89.8%16.8%-------51.4%
EPS growth, YoY-56.7%-13.9%-------50.4%
Gross margin31.0%35.2%35.2%33.8%4.1%26.1%28.9%23.7%27.5%39.0%
Operating margin13.6%7.4%17.5%16.2%-38.9%-17.4%0.7%-31.9%-15.2%20.9%
Net margin8.5%21.2%13.3%13.5%-39.8%-8.4%0.4%-24.9%-22.1%17.3%
Free cash flow margin--7.8%-5.3%8.8%-9.1%0.8%3.5%17.6%41.0%
Return on equity7.9%14.6%22.5%25.2%-71.2%-3.0%0.2%-8.7%-7.8%6.9%
Return on assets6.6%11.7%15.6%6.5%-12.7%-2.7%0.1%-8.0%-7.2%6.4%
Current ratio4.913.943.678.577.9510.099.0810.4610.0910.41
Debt to equity0.020.030.12-------

Source: XBRL data Innovex International Inc. files with the SEC, latest filing dated Nov 4, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

INVX peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
INVX$1.02B+7.0%$48.61M4.8%$1.78B
BKR$28.74B+3.7%$2.90B10.1%$48.11B
FTI$10.67B+9.1%$1.28B12.0%$24.88B
NOV$8.69B-1.0%$148.00M1.7%$6.30B
WFRD$4.69B-5.7%$409.00M8.7%$6.20B
WHD$1.53B+40.4%$183.90M12.0%$4.86B
SEI$936.43M+73.8%$90.23M9.6%$4.79B
DNOW$4.79B+96.8%-$186.00M-3.9%$2.51B
FLOC$901.22M+20.4%$57.32M6.4%$1.89B

INVX FAQ

8 questions
  • What is INVX revenue?
    Innovex International Inc. (INVX) reported $1.02B of revenue for the twelve months ended Sep 30, 2026. That is up 7.0% from the year before. Revenue for fiscal 2025 was $978.25M.
  • Is INVX profitable?
    Yes. Innovex International Inc. earned $48.61M in net income for the twelve months ended Sep 30, 2026, a net margin of 4.8%.
  • How much cash and debt does INVX have?
    Innovex International Inc. reported $188.76M in cash and cash equivalents and $18.27M of debt on its most recent balance sheet in SEC filings.
  • How fast is INVX revenue growing?
    Innovex International Inc.'s revenue changed +48.0% in fiscal 2025, to $978.25M. Its compound annual growth rate was +21.8% over 5 years and +1.5% over 10 years.
  • What is INVX gross margin?
    Innovex International Inc.'s gross profit was $343.15M on $1.02B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 33.6%.
  • What is INVX earnings per share?
    Diluted earnings per share were $0.69 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
  • When did INVX last report financial results?
    The latest statements here come from Innovex International Inc.'s 10-Q filed on Nov 4, 2026, covering the period ended Sep 30, 2026.
  • Where does this INVX financial data come from?
    Quantisnow builds these statements from the structured XBRL data Innovex International Inc. files with the SEC. It is provided for information only and is not investment advice.